The best under-invested medtech innovation opportunities
This is the year to put medtech investment to work. With macroeconomics improving, inflation easing and organizations stabilizing, now is the time to light the powder.
Cracking genomics needs biology and engineering to find a common language
The first company to deploy cost-effective genomic measurements in mainstream medicine will not only transform healthcare, but also create lasting business value. But why has no-one cracked it yet?
The precision medicine industry must work together to transform rare disease treatment
Precision medicine is leading to transformative patient treatments – but industry collaboration is needed to make sure patients with rare diseases are not left behind.
Metamorphosis: How converging deep tech will propel business in the new bioeconomy
Emerging deep tech like biotechnology and synthetic biology are shaping an exciting new bioeconomy. This CC Innovation Briefing offers a vision for its future, and explains how scalable, profitable and resilient bioprocesses will benefit businesses and sustainability.
Where does quantum technology sit as part of a system?
For many business leaders, quantum technology remains confusing and inaccessible. But it can feel more familiar when it takes its place as part of a wider system. Here Edmund Owen explains the keys to integrating quantum components into larger systems, existing value chains and business processes
Quantum computing adoption – it’s time to seize the initiative
Quantum technology commercial adoption will be gradual – but that doesn’t mean ambitious business leaders should adopt a wait and see approach.